Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CytoDyn Return on Investment 2010-2025 | CYDY

Current and historical return on investment (ROI) values for CytoDyn (CYDY) over the last 10 years.
  
CytoDyn ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-02-28 $0.01B 0.00%
2024-11-30 $0.01B 0.00%
2024-08-31 $0.01B 0.00%
2024-05-31 $-0.02B 0.00%
2024-02-29 $-0.02B 55.05%
2023-11-30 $-0.02B 58.72%
2023-08-31 $-0.04B 132.11%
2023-05-31 $-0.04B $-0.11B 150.46%
2023-02-28 $-0.12B 0.00%
2022-11-30 $-0.13B 0.00%
2022-08-31 $-0.13B 0.00%
2022-05-31 $-0.15B 0.00%
2022-02-28 $-0.09B 0.00%
2021-11-30 $-0.10B 0.00%
2021-08-31 $-0.10B 0.00%
2021-05-31 $-0.11B -2494.12%
2021-02-28 $-0.11B -1913.04%
2020-11-30 $-0.10B -1756.52%
2020-08-31 $-0.09B $0.02B -3520.00%
2020-05-31 $-0.08B $0.01B 2142.86%
2020-02-29 $-0.06B 871.43%
2019-11-30 $-0.05B $-0.01B 630.30%
2019-08-31 $-0.06B $-0.01B 829.63%
2019-05-31 $-0.06B $-0.01B 605.41%
2019-02-28 $-0.05B $-0.01B 731.03%
2018-11-30 $-0.05B $-0.01B 900.00%
2018-08-31 $-0.05B $-0.02B 1152.94%
2018-05-31 $-0.05B 0.00%
2018-02-28 $-0.04B 0.00%
2017-11-30 $-0.04B 0.00%
2017-08-31 $-0.03B 0.00%
2017-05-31 $-0.03B 0.00%
2017-02-28 $-0.03B 0.00%
2016-11-30 $-0.02B 0.00%
2016-08-31 $-0.02B 0.00%
2016-05-31 $-0.02B 0.00%
2016-02-29 $-0.03B 1250.00%
2015-11-30 $-0.02B 920.00%
2015-08-31 $-0.02B 920.00%
2015-05-31 $-0.02B $-0.01B 1085.71%
2015-02-28 $-0.01B $0.00B -685.71%
2014-11-30 $-0.01B $0.00B -266.67%
2014-08-31 $-0.01B $0.00B -151.72%
2014-05-31 $-0.01B $0.01B -133.33%
2014-02-28 $-0.01B $0.01B -145.45%
2013-11-30 $-0.01B $0.01B -200.00%
2013-08-31 $-0.01B $0.00B -933.33%
2013-05-31 $-0.01B $0.00B 1200.00%
2013-02-28 $-0.01B $0.00B 1000.00%
2012-11-30 $-0.01B $0.00B 514.29%
2012-08-31 $-0.01B $-0.01B 246.15%
2012-05-31 $-0.01B 171.43%
2012-02-29 $0.00B $0.00B 84.21%
2011-11-30 $0.00B $-0.01B 76.19%
2011-08-31 $0.00B $-0.01B 106.67%
2011-05-31 $0.00B $-0.01B 177.78%
2011-02-28 $-0.01B $0.00B 285.71%
2010-11-30 $-0.01B $0.00B 666.67%
2010-08-31 $-0.01B $0.00B 500.00%
2010-05-31 $0.00B $0.00B 400.00%
2010-02-28 $0.00B $0.00B 800.00%
2009-11-30 $0.00B $0.00B 200.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.316B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $93.202B 34.96
Zoetis (ZTS) United States $69.350B 26.25
Takeda Pharmaceutical (TAK) Japan $48.619B 10.76
Daiichi Sankyo, - (DSNKY) Japan $47.708B 24.27
Sandoz Group AG (SDZNY) Switzerland $19.609B 0.00
Astellas Pharma (ALPMY) Japan $18.241B 10.72
Merck (MKKGY) Germany $17.913B 14.82
Summit Therapeutics (SMMT) United States $17.424B 0.00
Shionogi (SGIOY) Japan $14.411B 14.44
United Therapeutics (UTHR) United States $13.508B 12.23
Neurocrine Biosciences (NBIX) United States $10.610B 32.60
IPSEN (IPSEY) France $9.463B 0.00
Orion OYJ (ORINY) Finland $8.841B 23.91
Corcept Therapeutics (CORT) United States $7.766B 59.06
Madrigal Pharmaceuticals (MDGL) United States $7.525B 0.00
Stevanato Group S.p.A (STVN) Italy $6.360B 40.38
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.739B 0.00
Soleno Therapeutics (SLNO) United States $3.757B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.119B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.961B 12.02
Hypermarcas (HYPMY) Brazil $2.534B 16.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.402B 14.90
Recursion Pharmaceuticals (RXRX) United States $2.299B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.037B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.827B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.766B 0.00
Indivior (INDV) United States $1.620B 6.87
Guardian Pharmacy Services (GRDN) United States $1.525B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.366B 174.00
Dyne Therapeutics (DYN) United States $1.332B 0.00
Ocular Therapeutix (OCUL) United States $1.306B 0.00
Ardelyx (ARDX) United States $1.299B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.110B 45.11
Enliven Therapeutics (ELVN) United States $0.915B 0.00
Harrow (HROW) United States $0.905B 0.00
Collegium Pharmaceutical (COLL) United States $0.887B 4.71
Avadel Pharmaceuticals (AVDL) Ireland $0.832B 0.00
AleAnna (ANNA) United States $0.790B 0.00
Xencor (XNCR) United States $0.753B 0.00
Cronos Group (CRON) Canada $0.713B 0.00
Xeris Biopharma Holdings (XERS) United States $0.690B 0.00
KalVista Pharmaceuticals (KALV) United States $0.650B 0.00
Bioventus (BVS) United States $0.619B 16.08
Organogenesis (ORGO) United States $0.619B 0.00
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Savara (SVRA) United States $0.563B 0.00
Relay Therapeutics (RLAY) United States $0.529B 0.00
USANA Health Sciences (USNA) United States $0.526B 11.29
Verve Therapeutics (VERV) United States $0.487B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.440B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.418B 0.00
Siga Technologies (SIGA) United States $0.412B 7.02
Zevra Therapeutics (ZVRA) United States $0.395B 0.00
Altimmune (ALT) United States $0.393B 0.00
Oruka Therapeutics (ORKA) United States $0.391B 0.00
Heron Therapeutics (HRTX) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 20.82
ProKidney (PROK) United States $0.316B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Avita Medical (RCEL) United States $0.264B 0.00
OmniAb (OABI) United States $0.226B 0.00
Regulus Therapeutics (RGLS) United States $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.221B 26.02
Wellgistics Health (WGRX) United States $0.209B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Esperion Therapeutics (ESPR) United States $0.190B 24.00
Journey Medical (DERM) United States $0.174B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Korro Bio (KRRO) United States $0.157B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.156B 0.00
Larimar Therapeutics (LRMR) United States $0.153B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.152B 47.01
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Profound Medical (PROF) Canada $0.147B 0.00
Aclaris Therapeutics (ACRS) United States $0.144B 0.00
Nektar Therapeutics (NKTR) United States $0.138B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.119B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.104B 17.09
VAXART, INC (VXRT) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
OptiNose (OPTN) United States $0.094B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Cassava Sciences (SAVA) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 8.29
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
BioVie (BIVI) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.08
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.16
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00